PARK2 Peptide

• NCBI Gene ID :

  5071

• Swiss Prot :

  O60260

• Accession Number :

  NP_004553

• Type :

  Peptides

• Concentration :

  200 ug/mL

• Buffer :

  PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin and 0.02% sodium azide

• Shipping Conditions :

  Blue Ice

• Storage Conditions :

  Store PARK2 Peptide at -20˚ C, stable for one year.

• Applications Notes :

  The peptide is used for blocking the activity of PARK2 Antibody (catalog number 7903) . It usually blocks the antibody activity completely by incubating the peptide with equal volume of antibody for 30 min at 37˚ C.

• NCBI Official Name :

  Parkin RBR E3 ubiquitin protein ligase

• NCBI Organism :

  Homo sapiens

• Background Reference 01 :

  Dauer W and Przedborski S. Parkinson’s disease: Mechanisms and models. Neuron 2003; 39:889-909.

• Background Reference 02 :

  Kitada T, Asakawa S, Hattori N, et al. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature 1998; 392:605-8.

• Background Reference 03 :

  Shimura H, Hattori N, Kubo Si, et al. Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase. Nat. Genet. 2000; 25:302-5.

• Background Reference 04 :

  Johnson BN, Berger AK, Cortese GP, et al. The ubiquitin E3 ligase parkin regulates the proapoptotic function of Bax. Proc. Natl. Acad. Sci. USA 2012; 109:6283-88.

• Other Product Names :

  PDJ, PRKN, AR-JP, LPRS2, E3 ubiquitin-protein ligase parkin, Parkinson juvenile disease protein 2, Parkinson disease protein 2

• Tested Applications :

  Blocking

• Species :

  Human

• Protein ID :

  169790969

• Physical Properties :

  Liquid